These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15932508)

  • 1. Respiratory syncytial virus and neutrophil activation.
    Bataki EL; Evans GS; Everard ML
    Clin Exp Immunol; 2005 Jun; 140(3):470-7. PubMed ID: 15932508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Respiratory syncytial virus infection enhances neutrophil and eosinophil adhesion to cultured respiratory epithelial cells. Roles of CD18 and intercellular adhesion molecule-1.
    Stark JM; Godding V; Sedgwick JB; Busse WW
    J Immunol; 1996 Jun; 156(12):4774-82. PubMed ID: 8648124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The respiratory syncytial virus fusion protein and neutrophils mediate the airway mucin response to pathogenic respiratory syncytial virus infection.
    Stokes KL; Currier MG; Sakamoto K; Lee S; Collins PL; Plemper RK; Moore ML
    J Virol; 2013 Sep; 87(18):10070-82. PubMed ID: 23843644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of respiratory syncytial virus-antibody complexes on cytokine (IL-8, IL-6, TNF-alpha) release and respiratory burst in human granulocytes.
    Arnold R; Werner F; Humbert B; Werchau H; König W
    Immunology; 1994 Jun; 82(2):184-91. PubMed ID: 7927487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The secreted form of respiratory syncytial virus G glycoprotein helps the virus evade antibody-mediated restriction of replication by acting as an antigen decoy and through effects on Fc receptor-bearing leukocytes.
    Bukreyev A; Yang L; Fricke J; Cheng L; Ward JM; Murphy BR; Collins PL
    J Virol; 2008 Dec; 82(24):12191-204. PubMed ID: 18842713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil-Airway Epithelial Interactions Result in Increased Epithelial Damage and Viral Clearance during Respiratory Syncytial Virus Infection.
    Deng Y; Herbert JA; Robinson E; Ren L; Smyth RL; Smith CM
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32295918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory syncytial virus infection of airway epithelial cells, in vivo and in vitro, supports pulmonary antibody responses by inducing expression of the B cell differentiation factor BAFF.
    McNamara PS; Fonceca AM; Howarth D; Correia JB; Slupsky JR; Trinick RE; Al Turaiki W; Smyth RL; Flanagan BF
    Thorax; 2013 Jan; 68(1):76-81. PubMed ID: 23002173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against respiratory syncytial virus by a recombinant Newcastle disease virus vector.
    Martinez-Sobrido L; Gitiban N; Fernandez-Sesma A; Cros J; Mertz SE; Jewell NA; Hammond S; Flano E; Durbin RK; García-Sastre A; Durbin JE
    J Virol; 2006 Feb; 80(3):1130-9. PubMed ID: 16414990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of human TLR4 in respiratory syncytial virus-induced NF-κB activation, viral entry and replication.
    Marr N; Turvey SE
    Innate Immun; 2012 Dec; 18(6):856-65. PubMed ID: 22535679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of respiratory syncytial virus G antigenicity to vaccine-enhanced illness and the implications for severe disease during primary respiratory syncytial virus infection.
    Johnson TR; Graham BS
    Pediatr Infect Dis J; 2004 Jan; 23(1 Suppl):S46-57. PubMed ID: 14730270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory syncytial virus-infected pulmonary epithelial cells induce eosinophil degranulation by a CD18-mediated mechanism.
    Olszewska-Pazdrak B; Pazdrak K; Ogra PL; Garofalo RP
    J Immunol; 1998 May; 160(10):4889-95. PubMed ID: 9590236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB/c mice.
    Fu Y; He J; Zheng X; Wu Q; Zhang M; Wang X; Wang Y; Xie C; Tang Q; Wei W; Wang M; Song J; Qu J; Zhang Y; Wang X; Hong T
    Biochem Biophys Res Commun; 2009 Apr; 381(4):528-32. PubMed ID: 19233131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate.
    Li X; Sambhara S; Li CX; Ettorre L; Switzer I; Cates G; James O; Parrington M; Oomen R; Du RP; Klein M
    Virology; 2000 Mar; 269(1):54-65. PubMed ID: 10725198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary airway epithelial cultures from children are highly permissive to respiratory syncytial virus infection.
    Fonceca AM; Flanagan BF; Trinick R; Smyth RL; McNamara PS
    Thorax; 2012 Jan; 67(1):42-8. PubMed ID: 21865207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophils induce damage to respiratory epithelial cells infected with respiratory syncytial virus.
    Wang SZ; Xu H; Wraith A; Bowden JJ; Alpers JH; Forsyth KD
    Eur Respir J; 1998 Sep; 12(3):612-8. PubMed ID: 9762789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of antibody-induced modulation of respiratory syncytial virus antigens in a human epithelial cell line.
    Sarmiento RE; Tirado RG; Valverde LE; Gómez-Garcia B
    Virol J; 2007 Jul; 4():68. PubMed ID: 17608950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory syncytial virus infection and the tight junctions of nasal epithelial cells.
    Tsutsumi H; Kojima T; Hirakawa S; Masaki T; Okabayashi T; Yokota S; Fujii N; Himi T; Sawada N
    Adv Otorhinolaryngol; 2011; 72():153-6. PubMed ID: 21865717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrafine carbon black particles enhance respiratory syncytial virus-induced airway reactivity, pulmonary inflammation, and chemokine expression.
    Lambert AL; Mangum JB; DeLorme MP; Everitt JI
    Toxicol Sci; 2003 Apr; 72(2):339-46. PubMed ID: 12655033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of airway eosinophil and neutrophil infiltration by alpha-galactosylceramide in a mouse model for respiratory syncytial virus (RSV) vaccine-augmented disease.
    Benoit AC; Huang Y; Maneewatchararangsri S; Tapchaisri P; Anderson R
    Vaccine; 2007 Nov; 25(45):7754-62. PubMed ID: 17920164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neutrophil activation and protease imbalance in respiratory tract of infants with respiratory syncytial virus bronchiolitis].
    Liu JL; Chen ZM
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(6):397-9. PubMed ID: 19567118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.